COO
The Cooper Companies, Inc.NASDAQHealthcare$70.17-1.76%ClosedMarket Cap: $13.69B
As of 2026-04-06
Valuation
P/E (TTM)
34.11
PEG
—
P/B
1.65
P/S
3.30
EV/EBITDA
16.70
DCF Value
$48.08
FCF Yield
3.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
64.2%
Operating Margin
17.2%
Net Margin
9.7%
ROE
4.8%
ROA
5.8%
ROIC
4.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.02B | 67.9% | $212.8M | $130.8M | $0.66 | — |
| Q4 2025 | $1.07B | 56.4% | $140.4M | $84.6M | $0.43 | — |
| FY 2025 | $4.09B | 60.7% | $682.9M | $374.9M | $1.87 | — |
| Q3 2025 | $1.06B | 65.3% | $175.7M | $98.3M | $0.49 | — |
| Q2 2025 | $1.00B | 67.8% | $184.8M | $87.7M | $0.44 | — |
| Q1 2025 | $964.7M | 68.4% | $182.0M | $104.3M | $0.52 | — |
| Q4 2024 | $1.02B | 66.5% | $198.4M | $117.5M | $0.58 | — |
| FY 2024 | $3.90B | 66.6% | $705.7M | $392.3M | $1.96 | — |
| Q3 2024 | $1.00B | 66.1% | $192.5M | $104.7M | $0.52 | — |
| Q2 2024 | $942.6M | 67.0% | $161.7M | $88.9M | $0.44 | — |
| Q1 2024 | $931.6M | 67.0% | $153.1M | $81.2M | $0.41 | — |
| Q4 2023 | $927.1M | 65.4% | $135.7M | $84.5M | $0.42 | — |